RESUMO
Leprosy (Hansen's Disease) has occurred throughout human history, and persists today at a low prevalence in most populations. Caused by Mycobacterium leprae, the infection primarily involves the skin, mucosa and peripheral nerves. The susceptible host range for Mycobacterium leprae is quite narrow. Besides humans, nine banded armadillos (Dasypus novemcinctus) and red squirrels (Sciurus vulgaris) are the only other natural hosts for M. leprae, but only armadillos recapitulate the disease as seen in humans. Armadillos across the Southern United States harbor a single predominant genotypic strain (SNP Type-3I) of M. leprae, which is also implicated in the zoonotic transmission of leprosy. We investigated, whether the zoonotic strain (3I) has any notable growth advantages in armadillos over another genetically distant strain-type (SNP Type-4P) of M. leprae, and if M. leprae strains manifest any notably different pathology among armadillos. We co-infected armadillos (nâ¯=â¯6) with 2â¯×â¯109 highly viable M. leprae of both strains and assessed the relative growth and dissemination of each strain in the animals. We also analyzed 12 additional armadillos, 6 each individually infected with the same quantity of either strain. The infections were allowed to fulminate and the clinical manifestations of the disease were noted. Animals were humanely sacrificed at the terminal stage of infection and the number of bacilli per gram of liver, spleen and lymph node tissue were enumerated by Q-PCR assay. The growth of M. leprae strain 4P was significantly higher (Pâ¯<â¯0.05) than 3I when each strain was propagated individually in armadillos. Significantly (Pâ¯<â¯0.0001) higher growth of the 4P strain also was confirmed among animals co-infected with both 3I and 4P strain types using whole genome sequencing. Interestingly, the zoonotic strain does not exhibit any growth advantage in these non-human hosts, but the varied proliferation of the two M. leprae strains within armadillos suggest there are notable pathological variations between M. leprae strain-types.
Assuntos
Tatus/microbiologia , Genótipo , Hanseníase/veterinária , Mycobacterium leprae/crescimento & desenvolvimento , Mycobacterium leprae/genética , Polimorfismo de Nucleotídeo Único , América/epidemiologia , Animais , Animais Selvagens , Variação Genética , Hanseníase/epidemiologia , Hanseníase/microbiologia , Camundongos , Mycobacterium leprae/classificação , ZoonosesRESUMO
The epidemiological situation of leprosy is reported by the health division of each country to WHO. The reported data is collected by WHO and is immediately run on the Weekly Epidemiological Record. On this latest edition, data from the beginning of 2010 was reported. The Enhanced global strategy for further reducing the disease burden due to leprosy (plan period: 2011-2015) emphasizes reducing grade-2 disabilities among new cases. The burden of leprosy continues to decline globally as a result of sustained efforts carried out by national leprosy programmes along with continued support from both national and international partners. Improving the management of complications through the development of an effective referral service and increased community awareness about the disease will ensure that cases present for diagnosis at an early stage and will help reduce the disease burden further.
Assuntos
Saúde Global/estatística & dados numéricos , Hanseníase/epidemiologia , Organização Mundial da Saúde , África/epidemiologia , América/epidemiologia , Ásia/epidemiologia , Austrália/epidemiologia , Europa (Continente)/epidemiologia , Feminino , Humanos , Masculino , Ilhas do Pacífico/epidemiologia , PrevalênciaRESUMO
Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae. This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes. Using comparative genomics, we demonstrated that all extant cases of leprosy are attributable to a single clone whose dissemination worldwide can be retraced from analysis of very rare single-nucleotide polymorphisms. The disease seems to have originated in Eastern Africa or the Near East and spread with successive human migrations. Europeans or North Africans introduced leprosy into West Africa and the Americas within the past 500 years.
Assuntos
Emigração e Imigração , Hanseníase/história , Mycobacterium leprae/genética , África/epidemiologia , América/epidemiologia , Ásia/epidemiologia , Evolução Biológica , Europa (Continente)/epidemiologia , Genes Bacterianos , Genoma Bacteriano , História do Século XVIII , História do Século XIX , História Antiga , História Medieval , Humanos , Sequências Repetitivas Dispersas , Hanseníase/epidemiologia , Hanseníase/microbiologia , Hanseníase/transmissão , Repetições Minissatélites , Mycobacterium leprae/classificação , Análise de Sequência com Séries de Oligonucleotídeos , Polimorfismo de Nucleotídeo Único , Dinâmica Populacional , Pseudogenes , Análise de Sequência de DNAAssuntos
Emigração e Imigração , Hanseníase/história , Mycobacterium leprae/genética , África Oriental/epidemiologia , África Ocidental , América/epidemiologia , Ásia/epidemiologia , DNA Bacteriano/genética , Europa (Continente)/epidemiologia , Genoma Bacteriano , História do Século XX , História Antiga , História Medieval , Humanos , Hanseníase/epidemiologia , Hanseníase/microbiologia , Hanseníase/transmissão , Mycobacterium leprae/classificação , Polimorfismo de Nucleotídeo Único , Problemas SociaisRESUMO
Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae. This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes. Using comparative genomics, we demonstrated that all extant cases of leprosy are attributable to a single clone whose dissemination worldwide can be retraced from analysis of very rare single-nucleotide polymorphisms. The disease seems to have originated in Eastern Africa or the Near East and spread with successive human migrations. Europeans or North Africans introduced leprosy into West Africa and the Americas within the past 500 years.
Assuntos
Humanos , História Antiga , História Medieval , História do Século XVIII , História do Século XIX , Ásia/epidemiologia , América/epidemiologia , Pseudogenes , Genoma Bacteriano , Análise de Sequência com Séries de Oligonucleotídeos , Polimorfismo de Nucleotídeo Único , África/epidemiologia , Emigração e Imigração , Europa (Continente)/epidemiologia , Genes Bacterianos , Hanseníase/história , Hanseníase/microbiologia , Hanseníase/transmissão , Hanseníase/epidemiologia , Mycobacterium leprae/classificação , Mycobacterium leprae/genéticaRESUMO
Trends in case detection and case detection rate (CDR) since 1985 are described at regional and national levels. Annual case detection by WHO Region was available for 1994-2000. Using different sources, complete time series for case detection were constructed for 1985-1998 for a group of 33 endemic countries cumulatively (top 33), and for 14 individual countries (top 14). Population statistics were used to derive CDRs. India contributed 79% to global case detection in 1998. Africa, the Americas and South-East Asia each contributed about 30% when India is excluded. During 1994-2000, case detection did not decrease in these three WHO Regions. The 33 countries contributed 99% and 98% to global case detection in 1994 and 1998, respectively. Cumulative case detection for the top 33 minus India gradually increased, overall almost doubling. The contribution of the top 14 to case detection of the top 33 hardly changed over time, equalling 96% in 1998 (81% when India is excluded). In terms of annual case detection, Brazil was always ranked second after India; it accounted for 27% of 1998 case detection in the top 33 except India. In 1998, seven of the top 14 countries--including India and Brazil--had CDRs above 2 per 10,000. The CDR did not exceed 1 per 10,000 for the other half. Decreasing tendencies in CDR, either for the whole period or in the 1990s, are observed for four of the top 14 countries (Guinea and three Western Pacific countries: China, Vietnam and the Philippines). In conclusion, there is no general decline in case detection to date, and several important countries still have high CDRs. Prevalence is an irrelevant indicator for monitoring epidemiological changes in leprosy. Trends in the transmission and incidence of leprosy are still completely unclear, necessitating further research. The target to eliminate leprosy as a public health problem, defined as a prevalence of less than 1 per 10,000, is therefore also an inadequate yardstick for decision making on leprosy control.
Assuntos
Controle de Doenças Transmissíveis/tendências , Doenças Endêmicas/estatística & dados numéricos , Hanseníase/epidemiologia , Hanseníase/prevenção & controle , África/epidemiologia , América/epidemiologia , Sudeste Asiático/epidemiologia , Controle de Doenças Transmissíveis/normas , Feminino , Previsões , Saúde Global , Promoção da Saúde , Humanos , Índia/epidemiologia , Hansenostáticos/uso terapêutico , Hanseníase/tratamento farmacológico , Masculino , Vigilância da População , Prevalência , Sistema de Registros , Índice de Gravidade de Doença , Organização Mundial da SaúdeAssuntos
Doenças Endêmicas/prevenção & controle , Hansenostáticos/uso terapêutico , Hanseníase/epidemiologia , Hanseníase/prevenção & controle , Adolescente , Adulto , África/epidemiologia , Distribuição por Idade , Idoso , América/epidemiologia , Ásia/epidemiologia , Criança , Quimioterapia Combinada , Humanos , Hanseníase/diagnóstico , Pessoa de Meia-Idade , Prevalência , Organização Mundial da SaúdeRESUMO
The European-American exchange of infectious diseases was responsible for the demographic havoc of the native population in the New World after 1492. Prior to this date medical writers describe the presence in Spain of viral diseases like influenza, parotitis, smallpox, measles, poliomyelitis, and rabies; there were also rickettsiasis, diphtheria, salmonellosis, plague, tubercolosis, leprosy, malaria, scabies and tinea. In America, before European arrivals, there were no records of human viral diseases, though there were records of rickettsiasis, treponematosis--pinta, yaws and syphilis--leihsmaniasis, amibiasis and perhaps leprosy. With the discovery of America in 1492, Columbus's sailors were contaminated by yaws and spread this disease into Europe. In 1493 influenza, as a zoonosis, was introduced into Santo Domingo and was responsible for the annihilation of the natives of the Antilles in less than a quarter of a century; in 1518 smallpox was also introduced in Santo Domingo and then to the American continent by negro slaves: by the same means measles were introduced in 1531. The previous existence or introduction of other infectious diseases in America is also discussed.
Assuntos
Doenças Transmissíveis/história , Indígenas Norte-Americanos/história , Indígenas Sul-Americanos/história , Viagem/história , América/epidemiologia , Doenças Transmissíveis/epidemiologia , Doenças Transmissíveis/transmissão , Emigração e Imigração/história , Europa (Continente)/epidemiologia , História do Século XV , História do Século XVI , História do Século XVII , História do Século XVIII , História do Século XIX , História Antiga , HumanosRESUMO
En primer lugra se expone el origen de la lepra y su llegada a la Península Ibérica y su posterior expansión a América después del descubrimiento. Después, se actualiza la endemia en los diferentes países americanos y su tendencia a aumentar, insistiéndose en la necesidad de extender la multiterapia a todos los casos para conseguir la erradicación en la próxima década.